Search company, investor...

Predict your next investment

ArrowMark Partners company logo
Asset/Investment Management
arrowmarkpartners.com

Investments

64

Portfolio Exits

29

Funds

1

About ArrowMark Partners

ArrowMark Partners is an investment adviser that facilitates cross-discipline collaboration and knowledge-sharing across credit, equity, commercial real estate public, and private markets. The company was founded in 2007 and is based in Denver, Colorado.

Headquarters Location

100 Fillmore Street Suite 325

Denver, Colorado, 80206,

United States

Want to inform investors similar to ArrowMark Partners about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Expert Collections containing ArrowMark Partners

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find ArrowMark Partners in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

Latest ArrowMark Partners News

Beta Bionics

Sep 5, 2023

美国临床阶段人造胰腺研发机构,完成1亿美元D轮融资,投资方为Sands Capital、Omega Funds、Marshall Wace领投,Soleus Capital、Eventide Asset Management LLC、Farallon Capital法拉龙资本、Perceptive Advisors、RTW、LP、ArrowMark Partners、Pura Vida Investments跟投。

ArrowMark Partners Investments

64 Investments

ArrowMark Partners has made 64 investments. Their latest investment was in Beta Bionics as part of their Series D on August 8, 2023.

CBI Logo

ArrowMark Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/30/2023

Series D

Beta Bionics

$100M

No

5

7/18/2023

Series C

Neurogene

$95M

No

2

9/28/2022

Series C

Checkerspot

$55M

Yes

3

9/23/2022

PIPE

Subscribe to see more

$99M

Subscribe to see more

10

8/25/2022

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/30/2023

7/18/2023

9/28/2022

9/23/2022

8/25/2022

Round

Series D

Series C

Series C

PIPE

Series A - II

Company

Beta Bionics

Neurogene

Checkerspot

Subscribe to see more

Subscribe to see more

Amount

$100M

$95M

$55M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

5

2

3

10

10

ArrowMark Partners Portfolio Exits

29 Portfolio Exits

ArrowMark Partners has 29 portfolio exits. Their latest portfolio exit was Neurogene on July 18, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/18/2023

Acq - Pending

$99M

2

4/12/2022

Corporate Majority

$99M

3

12/21/2021

Acquired

$99M

10

10/29/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

8/6/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/18/2023

4/12/2022

12/21/2021

10/29/2021

8/6/2021

Exit

Acq - Pending

Corporate Majority

Acquired

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

2

3

10

10

10

ArrowMark Partners Acquisitions

2 Acquisitions

ArrowMark Partners acquired 2 companies. Their latest acquisition was StoneCastle Cash Management - Bank Investment Platform on February 13, 2020.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

2/13/2020

$99M

Acquired Unit

1

12/9/2019

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/13/2020

12/9/2019

Investment Stage

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

Note

Acquired Unit

Subscribe to see more

Sources

1

10

ArrowMark Partners Fund History

1 Fund History

ArrowMark Partners has 1 fund, including Global Opportunity Fund IV.

Closing Date

Fund

Fund Type

Status

Amount

Sources

5/25/2023

Global Opportunity Fund IV

$1,100M

1

Closing Date

5/25/2023

Fund

Global Opportunity Fund IV

Fund Type

Status

Amount

$1,100M

Sources

1

ArrowMark Partners Team

4 Team Members

ArrowMark Partners has 4 team members, including current Founding Partner, Minyoung Sohn.

Name

Work History

Title

Status

Minyoung Sohn

Founding Partner

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Minyoung Sohn

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Founding Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.